Pnc Financial Services Group, Inc. Rhythm Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 4,518 shares of RYTM stock, worth $267,375. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,518
Previous 304
1386.18%
Holding current value
$267,375
Previous $16,000
1393.75%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RYTM
# of Institutions
245Shares Held
62.9MCall Options Held
403KPut Options Held
62.8K-
Black Rock Inc. New York, NY6.74MShares$399 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$360 Million6.69% of portfolio
-
Primecap Management CO Pasadena, CA5.79MShares$342 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$332 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$204 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.3B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...